Postoperative chemotherapy in non-small cell lung cancer: Still more questions than answers

Future Oncology

Volumn 2, Issue 5, 2006, Pages 569-571

  Jassem, Jacek ^a  

^a MEDICAL UNIVERSITY OF GDANSK   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; CISPLATIN; ETOPOSIDE; EXCISION REPAIR CROSS COMPLEMENTING PROTEIN 1; GEMCITABINE; MITOMYCIN; NAVELBINE; PACLITAXEL; PLATINUM COMPLEX; TAXANE DERIVATIVE; VINBLASTINE; VINCA ALKALOID;

CANCER CHEMOTHERAPY; CANCER INCIDENCE; CANCER RADIOTHERAPY; CANCER RELAPSE; CANCER SURVIVAL; CLINICAL TRIAL; EDITORIAL; HUMAN; LUNG NON SMALL CELL CANCER; LUNG RESECTION; PATIENT COMPLIANCE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; UNSPECIFIED SIDE EFFECT;

AGED; CARCINOMA, NON-SMALL-CELL LUNG; CHEMOTHERAPY, ADJUVANT; HUMANS; MIDDLE AGED; POSTOPERATIVE PERIOD;

EID: 33750037918     PISSN: 14796694     EISSN: 17448301     Source Type: Journal    
DOI: 10.2217/14796694.2.5.569     Document Type: Editorial

References (14)

1. PORT Meta-analysis Trialists Group: Postoperative radiotherapy in non-small-cell lung cancer: systematic review and meta-analysis of individual patient data from nine randomised controlled trials. Lancet 352(9124), 257-263 (1998).
2. Non-Small Cell Lung Cancer Collaborative Group: Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomized trials. Br. Med. J. 311, 899-909 (1995).
3. Keller SM, Adak S, Wagner H et al.: A randomized trial of postoperative adjuvant therapy in patients with completely resected Stage II or IIIA non-small cell lung cancer. N. Engl. J. Med. 343(17), 1217-1222 (2000).
4. Scagliotti GV, Fossati R, Torri V et al.: Randomized study of adjuvant chemotherapy for completely resected stage I, II or IIIA non-small cell lung cancer. J. Natl Cancer Inst. 95(19), 1453-1461 (2003).
5. The International Adjuvant Lung Cancer Trial Collaborative Group: Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small cell lung cancer. N. Engl. J. Med. 350(4), 351-360 (2004).
6. Winton T, Livingston R, Johnson D et al.: Vinorelbine plus cisplatin vs. observation in resected non-small-cell lung cancer. N. Engl. J. Med. 352(25), 2589-2597 (2005).
7. Douillard J, Rosell R, Delena M et al.: ANITA: Phase III adjuvant vinorelbine (N) and cisplatin (P) versus observation (OBS) in completely resected (Stage I-III) non-small-cell lung cancer (NSCLC) patients (pts): final results after 70-month median follow-up. Proceedings of the Annual Meeting of the American Society of Clinical Oncology. Orlando, FL, USA, 13-17 May 2005.
8. Strauss GM, Herndon J, Maddaus DW et al.: Randomized clinical trial of adjuvant chemotherapy with paclitaxel and carboplatin following resection in stage IB non-small cell lung cancer (NSCLC): Report of Cancer and Leukemia Group B (CALGB) protocol 9633. Proceedings of the Annual Meeting of the American Society of Clinical Oncology. New Orleans. LA, USA, 5-8 June 2004.
9. Pignon JP, Tribodet H, Scagliotti GV et al.: Lung Adjuvant Cisplatin Evaluation (LACE): a pooled analysis of five randomized clinical trials including 4584 patients. Proceedings of the Annual Meeting of the American Society of Clinical Oncology. Atlanta, GA, USA, 2-6 June 2006.
10. Strauss GM, Herndon JE, Maddaus MA et al. Adjuvant chemotherapy in stage IB non-small cell lung cancer (NSCLC): update of Cancer and Leukemia Group B (CALGB) protocol 9633. Proceedings of the Annual Meeting of the American Society of Clinical Oncology. Atlanta, GA, USA, 2-6 June 2006.
11. Hotta K, Matsuo K, Ueoka H et al.: Meta-analysis of randomized clinical trials comparing cisplatin to carboplatin in patients with advanced non-small cell lung cancer. J. Clin. Oncol. 22(19), 3852-3867 (2004).
12. Ardizzoni A, Tiseo M, Boni L et al.: CISCA (cisplatin vs carboplatin) meta-analysis: an individual patient data meta-analysis comparing cisplatin versus carboplatin-based chemotherapy in first-line treatment of advanced non-small cell lung cancer (NSCLC). Proceedings of the Annual Meeting of the American Society of Clinical Oncology. Atlanta, GA, USA, 2-6 June 2006.
13. Pepe C, Hasan B, Winton T et al.: Adjuvant chemotherapy in elderly patients: an analysis of National Cancer Institute of Canada Clinical Trials Group and Intergroup BR.10. Proceedings of the Annual Meeting of the American Society of Clinical Oncology. Atlanta, GA, USA, 2-6 June 2006.
14. Olaussen KA, Dunant A, Fouret P et al.: DNA repair by ERCC1 in non-small-cell lung cancer and cisplatin-based adjuvant chemotherapy. N. Engl. J. Med. 355(10), 983-991 (2006).